Clinical Trials on Retinal Neovascularization

Total 14192 results

Federico II University

Completed

Dark Halo and MNV: a Study Between ICGA and OCTA

Macular Neovascularisation

Italy
Poitiers University Hospital

Terminated

Resveratrol for Exudative Age-Related Macular Degeneration (AGED)

Age-related Macular Degeneration | AMD | Choroidal Neovascularisation

France
Singapore National Eye Centre

Unknown

Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy

Polypoidal Choroidal Vasculopathy | Choroidal Neovascularisation
Moorfields Eye Hospital NHS Foundation Trust
Novartis

Completed

Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study (RaDiVit)

Diabetic Retinopathy | Retinal Neovascularisation

United Kingdom
Medical University of Vienna

Completed

Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study

Keratoconus | Corneal Neovascularisation

Austria
University of Nottingham

Unknown

Strategies for Management of Corneal Neovascularisation

Corneal Neovascularisation
Sohag University

Not yet recruiting

OCTA Changes in Choroidal Neovascularization in High Myopia

Myopic Choroidal Neovascularisation
Instituto de Olhos de Goiania

Unknown

Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization (AflibxMyopia)

Choroidal Retinal Neovascularization

Brazil
Medical University of Vienna

Completed

Choroidal Blood Flow and Progression of Age-Related Macular Degeneration in the Fellow Eye in Patients With Unilateral Choroidal Neovascularisation

Regional Blood Flow

Austria
Notal Vision Inc.

Recruiting

Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD

Retinal Neovascularization

United States
Notal Vision Inc.

Completed

Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.

Retinal Neovascularization

United States
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Study of the Modification of the Retinal Nerve Fiber Layer in Patients Treated With Intravitreous Injection of Anti-VEGF (IVT-RNFL)

Retinal Neovascularization

France
Ophthalmological Association Edelweiss

Completed

Intravitreal Avastin in Proliferative Retinopathies (SITE-App)

Retinal Neovascularization

Romania
Zhongshan Ophthalmic Center, Sun Yat-sen University

Completed

Intravitreal Conbercept Injection in Patients With Myopic Choroidal Neovascularization

Myopic Choroidal Neovascularisation

China
Poitiers University Hospital

Active, not recruiting

Real Life Study in Myopic Neovascularization (VIC)

Myopic Choroidal Neovascularisation

France
AnewPharma

Suspended

CM082 in Patients With Myopic Choroidal Neovascularization (CNV)

Myopic Choroidal Neovascularisation

China
University Hospital, Ghent

Recruiting

Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema

Macular Edema | Retinal Neovascularization

Belgium
Novartis

Completed

Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen (REPAIR)

Choroidal Neovascularisation

United Kingdom
VISUfarma SpA
CROlife

Not yet recruiting

VISUPRIME® Eye Drops

Diabetic Macular Edema | Proliferative Diabetic Retinopathy | Macular Degeneration, Age Related | Myopic Choroidal Neovascularisation | Macular Edema of Right Retina (Diagnosis)

Italy
Tianjin Medical University

Terminated

Clinical Research on Retinal Neovascularization of Diabetic Retinopathy

The Mechanism of Retinal Neovascularization of Diabetic | Retinopathy.

China
University of Melbourne

Completed

Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration

Choroidal Neovascularization | Retinal Pigment Epithelial Detachment

Australia
Federico II University

Recruiting

Deep Learning OCT and OCTA in NVC

Macular Degeneration Choroidal Neovascularization

Italy
Salutaris Medical Devices, Inc.

Active, not recruiting

Episcleral Brachytherapy for the Treatment of Wet AMD (NEAMES)

Macular Degeneration, Choroidal Neovascularization

United States
Allergan

Terminated

Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration

Age-Related Maculopathy | Subfoveal Choroidal Neovascularization

United States
Hoffmann-La Roche

Completed

Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (STAIRWAY)

Macular Degeneration, Age-Related | Neovascularization, Choroidal

United States
Center for Eye Research Australia
Novartis Pharmaceuticals

Terminated

Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging

Macular Degeneration | Choroidal Neovascularization

Australia
Steba Biotech S.A.

Terminated

Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD

Macular Degeneration | Choroidal Neovascularization

United States, France
Brandon G. Busbee, MD
Genentech, Inc.

Completed

Evaluation of Dosing Interval of Higher Doses of Ranibizumab (BGB/IST)

Macular Degeneration | Choroidal Neovascularization

United States
Mid-Atlantic Retina Consultations, Inc.

Completed

Photodynamic and Pharmacologic Treatment of CNV (PBS)

Macular Degeneration | Choroidal Neovascularization
National Eye Institute (NEI)

Completed

Fluocinolone Implant to Treat Macular Degeneration

Macular Degeneration | Choroidal Neovascularization

United States
Eyetech Pharmaceuticals

Completed

Phase II/III Study of Anti-VEGF in Neovascular AMD

Macular Degeneration | Choroidal Neovascularization

United States
Theragenics Corporation

Unknown

Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System

Macular Degeneration | Choroidal Neovascularization

United States
Bayer

Completed

Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece (PERSEUS-GR)

Macular Degeneration | Choroidal Neovascularization

Greece
TargeGen

Terminated

Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD

Macular Degeneration | Choroidal Neovascularization

United States
Light Sciences LLC

Terminated

Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease

Macular Degeneration | Choroidal Neovascularization

United States
Pfizer

Terminated

An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD (PERSPECTIVES)

Macular Degeneration | Age Related Macular Degeneration (AMD) | Choroidal Neovascularization (CNV)

Canada, Belgium, United Kingdom, France, Poland, Spain, Turkey, Czech Republic, Italy, Greece, Germany, Austria, Portugal, Denmark, Finland
Genentech, Inc.

Completed

A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

Macular Degeneration

United States
Novartis

Completed

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

Macular Degeneration | Choroidal Neovascularization

United States, Canada
Vitreous -Retina- Macula Consultants of New York
Genentech, Inc.

Withdrawn

Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Choroidal Neovascularization

United States
QLT Inc.

Completed

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL) (RADICAL)

Macular Degeneration | Choroidal Neovascularization

United States, Canada
Shanghai University of Traditional Chinese Medicine

Completed

A Population-based Study of Macular Choroidal Neovascularization in a Chinese Population

Geographic Atrophy | Wet Macular Degeneration | Retinal Drusen

China
Novartis Pharmaceuticals
QLT Inc.

Completed

A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib (VERITAS)

Macular Degeneration | Choroidal Neovascularization

United States
Novartis

Terminated

Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

Macular Degeneration | Choroidal Neovascularization

United Kingdom, Spain, Netherlands, Hungary, Italy, Denmark, Belgium, Austria, France, Germany, Poland, Switzerland
Retinal Consultants Medical Group

Completed

Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD

Macular Degeneration | Choroidal Neovascularization

United States
University of Utah
National Eye Institute (NEI)

Recruiting

Impact of Non-Exudative Type 1 MNV on AMD Progression

Age-Related Macular Degeneration | Neovascularization, Choroidal

United States
Allergan

Terminated

A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration

Age-Related Macular Degeneration | Choroid Neovascularization

United States, Australia, Philippines
Medical University of Vienna

Withdrawn

Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?

Age-Related Macular Degeneration | Choroidal NeoVascularization

Austria
Allergan

Completed

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)

Choroidal Neovascularization | Age-Related Maculopathy

France, Korea, Republic of, New Zealand, Italy, Israel, United States, Portugal, Australia, United Kingdom
Allergan

Completed

Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)

Choroidal Neovascularization | Age-Related Maculopathy

United States, Australia, Philippines
Medical University of Vienna

Completed

Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Age-Related Macular Degeneration | Neovascularization, Choroidal

Austria

Clinical Trials on Retinal Neovascularization

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations